Incidence and predictors of antiretroviral resistance in perinatally HIV-1 infected children and adolescents

Objectives Individuals with perinatally acquired HIV infection have benefited from antiretroviral therapy. However, they often have complex patterns of major resistance mutations that limit the effectiveness of available antiretroviral medications. Knowledge of incidence rates of major antiretrovira...

Full description

Autores:
Contreras, German A.
Bell, Cynthia S.
Del Bianco, Gabriela
Pérez, Norma
Benjamins, Laura
Kleinosky, Matthew T.
Rodriguez, Gilhen
Murphy, James R.
Heresi, Gloria P.
Tipo de recurso:
Article of journal
Fecha de publicación:
2016
Institución:
Universidad El Bosque
Repositorio:
Repositorio U. El Bosque
Idioma:
eng
OAI Identifier:
oai:repositorio.unbosque.edu.co:20.500.12495/3635
Acceso en línea:
http://hdl.handle.net/20.500.12495/3635
https://doi.org/10.1016/j.jinf.2015.12.005
https://repositorio.unbosque.edu.co
Palabra clave:
Incidence rate
Adolescents
HIV
Antiretroviral resistance
Cumulative viral load
Rights
openAccess
License
Acceso abierto
id UNBOSQUE2_b364e8faaf6696e20435a14931b0434c
oai_identifier_str oai:repositorio.unbosque.edu.co:20.500.12495/3635
network_acronym_str UNBOSQUE2
network_name_str Repositorio U. El Bosque
repository_id_str
dc.title.spa.fl_str_mv Incidence and predictors of antiretroviral resistance in perinatally HIV-1 infected children and adolescents
dc.title.translated.spa.fl_str_mv Incidence and predictors of antiretroviral resistance in perinatally HIV-1 infected children and adolescents
title Incidence and predictors of antiretroviral resistance in perinatally HIV-1 infected children and adolescents
spellingShingle Incidence and predictors of antiretroviral resistance in perinatally HIV-1 infected children and adolescents
Incidence rate
Adolescents
HIV
Antiretroviral resistance
Cumulative viral load
title_short Incidence and predictors of antiretroviral resistance in perinatally HIV-1 infected children and adolescents
title_full Incidence and predictors of antiretroviral resistance in perinatally HIV-1 infected children and adolescents
title_fullStr Incidence and predictors of antiretroviral resistance in perinatally HIV-1 infected children and adolescents
title_full_unstemmed Incidence and predictors of antiretroviral resistance in perinatally HIV-1 infected children and adolescents
title_sort Incidence and predictors of antiretroviral resistance in perinatally HIV-1 infected children and adolescents
dc.creator.fl_str_mv Contreras, German A.
Bell, Cynthia S.
Del Bianco, Gabriela
Pérez, Norma
Benjamins, Laura
Kleinosky, Matthew T.
Rodriguez, Gilhen
Murphy, James R.
Heresi, Gloria P.
dc.contributor.author.none.fl_str_mv Contreras, German A.
Bell, Cynthia S.
Del Bianco, Gabriela
Pérez, Norma
Benjamins, Laura
Kleinosky, Matthew T.
Rodriguez, Gilhen
Murphy, James R.
Heresi, Gloria P.
dc.subject.keywords.spa.fl_str_mv Incidence rate
Adolescents
HIV
Antiretroviral resistance
Cumulative viral load
topic Incidence rate
Adolescents
HIV
Antiretroviral resistance
Cumulative viral load
description Objectives Individuals with perinatally acquired HIV infection have benefited from antiretroviral therapy. However, they often have complex patterns of major resistance mutations that limit the effectiveness of available antiretroviral medications. Knowledge of incidence rates of major antiretroviral resistance mutations should provide a benchmark enabling comparisons of different HIV care delivery modalities. Methods We test the hypothesis that incidence rate of major antiretroviral resistance mutations will decline with improvement in HIV care between 1998 and 2009 to NRTI, NNRTI, PI and triple class resistance in perinatally HIV infected individuals. Logistic regression is used to evaluate predictors of single and triple class resistance. Results Sixty-six individuals are included from a total population of 97 perinatally HIV infected individuals. The incidence rate of NRTI, NNRTI, PI and triple class resistance decreases with decreasing age in parallel with the introduction of new HIV treatment regimens. The youngest children (born 2000–2007) are free of triple class resistance. Mono-therapy associates with major resistance mutations to NRTI (OR 8.7, CI 1.5–50.9, P 0.02); NNRTI exposure associates with major resistance mutations to NNRTI (OR 24.4, CI 5.7–104.5, P 0.01) and triple class resistance (OR 10.7, CI 1.8–67.1, P 0.01). Cumulative viral load is an important predictor of PI resistance (OR 4.0, CI 1.3–12.3, P 0.02). Conclusions There is a progressive decrease in the incidence rate of major resistance mutations to antiretroviral drugs and triple class resistance from the oldest to the youngest birth cohort; where adolescents have the highest risk of harboring resistant viruses. The incidence rate of major antiretroviral resistance mutations provides a benchmark for the comparative measurement of effectiveness of different HIV care delivery modalities.
publishDate 2016
dc.date.issued.none.fl_str_mv 2016
dc.date.accessioned.none.fl_str_mv 2020-07-31T15:31:07Z
dc.date.available.none.fl_str_mv 2020-07-31T15:31:07Z
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.local.none.fl_str_mv Artículo de revista
dc.type.coar.none.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.driver.none.fl_str_mv info:eu-repo/semantics/article
format http://purl.org/coar/resource_type/c_6501
dc.identifier.issn.none.fl_str_mv 0163-4453
dc.identifier.uri.none.fl_str_mv http://hdl.handle.net/20.500.12495/3635
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1016/j.jinf.2015.12.005
dc.identifier.instname.spa.fl_str_mv instname:Universidad El Bosque
dc.identifier.reponame.spa.fl_str_mv reponame:Repositorio Institucional Universidad El Bosque
dc.identifier.repourl.none.fl_str_mv https://repositorio.unbosque.edu.co
identifier_str_mv 0163-4453
instname:Universidad El Bosque
reponame:Repositorio Institucional Universidad El Bosque
url http://hdl.handle.net/20.500.12495/3635
https://doi.org/10.1016/j.jinf.2015.12.005
https://repositorio.unbosque.edu.co
dc.language.iso.none.fl_str_mv eng
language eng
dc.relation.ispartofseries.spa.fl_str_mv Journal of Infection, 0163-4453, Vol. 72, Nro. 3, 2016, p.353-361
dc.relation.uri.none.fl_str_mv https://www.sciencedirect.com/science/article/abs/pii/S016344531500393X
dc.rights.local.spa.fl_str_mv Acceso abierto
dc.rights.accessrights.none.fl_str_mv http://purl.org/coar/access_right/c_abf2
info:eu-repo/semantics/openAccess
Acceso abierto
dc.rights.creativecommons.none.fl_str_mv 2016-03
rights_invalid_str_mv Acceso abierto
http://purl.org/coar/access_right/c_abf2
2016-03
eu_rights_str_mv openAccess
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Elsevier
dc.publisher.journal.spa.fl_str_mv Journal of Infection
institution Universidad El Bosque
bitstream.url.fl_str_mv https://repositorio.unbosque.edu.co/bitstreams/347e33b1-df4f-4041-be5a-f20f7712649d/download
https://repositorio.unbosque.edu.co/bitstreams/e6728683-ab60-4153-8851-f9629d85e5b2/download
https://repositorio.unbosque.edu.co/bitstreams/2d278e26-78e8-4fb5-9033-30f817ee5daa/download
https://repositorio.unbosque.edu.co/bitstreams/f72c77d5-f504-4707-b807-2b12a930f9d2/download
bitstream.checksum.fl_str_mv 8a4605be74aa9ea9d79846c1fba20a33
cb1da97507c6949cf934360f995e0ba5
7210a811635d1799e7c05fee5d259be7
654216fd5b500f010503fd36821b133d
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional Universidad El Bosque
repository.mail.fl_str_mv bibliotecas@biteca.com
_version_ 1814100703740690432
spelling Contreras, German A.Bell, Cynthia S.Del Bianco, GabrielaPérez, NormaBenjamins, LauraKleinosky, Matthew T.Rodriguez, GilhenMurphy, James R.Heresi, Gloria P.2020-07-31T15:31:07Z2020-07-31T15:31:07Z20160163-4453http://hdl.handle.net/20.500.12495/3635https://doi.org/10.1016/j.jinf.2015.12.005instname:Universidad El Bosquereponame:Repositorio Institucional Universidad El Bosquehttps://repositorio.unbosque.edu.coapplication/pdfengElsevierJournal of InfectionJournal of Infection, 0163-4453, Vol. 72, Nro. 3, 2016, p.353-361https://www.sciencedirect.com/science/article/abs/pii/S016344531500393XIncidence and predictors of antiretroviral resistance in perinatally HIV-1 infected children and adolescentsIncidence and predictors of antiretroviral resistance in perinatally HIV-1 infected children and adolescentsArtículo de revistahttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articlehttp://purl.org/coar/version/c_970fb48d4fbd8a85Incidence rateAdolescentsHIVAntiretroviral resistanceCumulative viral loadObjectives Individuals with perinatally acquired HIV infection have benefited from antiretroviral therapy. However, they often have complex patterns of major resistance mutations that limit the effectiveness of available antiretroviral medications. Knowledge of incidence rates of major antiretroviral resistance mutations should provide a benchmark enabling comparisons of different HIV care delivery modalities. Methods We test the hypothesis that incidence rate of major antiretroviral resistance mutations will decline with improvement in HIV care between 1998 and 2009 to NRTI, NNRTI, PI and triple class resistance in perinatally HIV infected individuals. Logistic regression is used to evaluate predictors of single and triple class resistance. Results Sixty-six individuals are included from a total population of 97 perinatally HIV infected individuals. The incidence rate of NRTI, NNRTI, PI and triple class resistance decreases with decreasing age in parallel with the introduction of new HIV treatment regimens. The youngest children (born 2000–2007) are free of triple class resistance. Mono-therapy associates with major resistance mutations to NRTI (OR 8.7, CI 1.5–50.9, P 0.02); NNRTI exposure associates with major resistance mutations to NNRTI (OR 24.4, CI 5.7–104.5, P 0.01) and triple class resistance (OR 10.7, CI 1.8–67.1, P 0.01). Cumulative viral load is an important predictor of PI resistance (OR 4.0, CI 1.3–12.3, P 0.02). Conclusions There is a progressive decrease in the incidence rate of major resistance mutations to antiretroviral drugs and triple class resistance from the oldest to the youngest birth cohort; where adolescents have the highest risk of harboring resistant viruses. The incidence rate of major antiretroviral resistance mutations provides a benchmark for the comparative measurement of effectiveness of different HIV care delivery modalities.Acceso abiertohttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessAcceso abierto2016-03LICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://repositorio.unbosque.edu.co/bitstreams/347e33b1-df4f-4041-be5a-f20f7712649d/download8a4605be74aa9ea9d79846c1fba20a33MD52ORIGINALContreras, German A. I.pdfContreras, German A. I.pdfapplication/pdf633716https://repositorio.unbosque.edu.co/bitstreams/e6728683-ab60-4153-8851-f9629d85e5b2/downloadcb1da97507c6949cf934360f995e0ba5MD51THUMBNAILContreras, German A. I.pdf.jpgContreras, German A. I.pdf.jpgimage/jpeg5775https://repositorio.unbosque.edu.co/bitstreams/2d278e26-78e8-4fb5-9033-30f817ee5daa/download7210a811635d1799e7c05fee5d259be7MD53TEXTContreras, German A. I.pdf.txtContreras, German A. I.pdf.txtExtracted texttext/plain36427https://repositorio.unbosque.edu.co/bitstreams/f72c77d5-f504-4707-b807-2b12a930f9d2/download654216fd5b500f010503fd36821b133dMD5420.500.12495/3635oai:repositorio.unbosque.edu.co:20.500.12495/36352024-02-06 22:56:42.634restrictedhttps://repositorio.unbosque.edu.coRepositorio Institucional Universidad El Bosquebibliotecas@biteca.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